Reply to T.j. Herzog et Al.
Massey Cancer Center, Virginia Commonwealth University, Richmond, VA wmcguire52@aol.com.
William P
WP
McGuire
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors*; D013449:Sulfonamides / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D040262:Receptors, Vascular Endothelial Growth Factor